Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
8.28
-0.44 (-5.05%)
At close: Nov 20, 2024, 4:00 PM
8.61
+0.33 (3.99%)
After-hours: Nov 20, 2024, 5:37 PM EST
Olema Pharmaceuticals Employees
Olema Pharmaceuticals had 74 employees as of December 31, 2023. The number of employees decreased by 12 or -13.95% compared to the previous year.
Employees
74
Change (1Y)
-12
Growth (1Y)
-13.95%
Revenue / Employee
n/a
Profits / Employee
-$1,657,824
Market Cap
474.09M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 74 | -12 | -13.95% |
Dec 31, 2022 | 86 | 12 | 16.22% |
Dec 31, 2021 | 74 | 37 | 100.00% |
Dec 31, 2020 | 37 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Pacific Biosciences of California | 796 |
MeiraGTx Holdings | 425 |
Xeris Biopharma Holdings | 377 |
REGENXBIO | 344 |
Esperion Therapeutics | 240 |
OmniAb | 106 |
Y-mAbs Therapeutics | 100 |
Zevra Therapeutics | 69 |
OLMA News
- 8 days ago - Olema Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 15 days ago - Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Olema Oncology Presents Compelling New Preclinical Data Demonstrating Anti-Tumor Activity for OP-3136 with Enhanced Activity of Palazestrant Combinations at ENA 2024 - GlobeNewsWire
- 6 weeks ago - Olema Oncology Announces New Preclinical Combination Data to be Presented at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 3 months ago - Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Olema Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - Olema Oncology to Participate in Upcoming Investor Conferences in June - GlobeNewsWire